Alzheimer's Association International Conference | July 22-26, 2018, Chicago, United States
Scientific Sessions
The schedule below reflects the invited program only. The complete schedule, including the submitted program, will be available closer to the conference.
10:30 - 11:15 a.m.
Association Welcome
Session: PL-01-01
11:15 - 11:45 a.m.
Aberrant Network Activity in Alzheimer’s Disease – Preclinical Investigation to Clinical Trials
Lennart Mucke, M.D.
Gladstone Institute of Neurological Disease, United States
Theme: Therapeutics
Session: PL-01-02
10:30 – 11 a.m.
Multimodal Lifestyle Interventions
Miia Kivipelto, Ph.D.
Karolinska Institutet; Karolinska University Hospital, Sweden
Theme: Therapeutics
Session: PL-02-01
11 - 11:30 a.m.
The Aging Brain and the Risk for Alzheimer’s Disease
Denise Park, Ph.D.
The University of Texas, Dallas, United States
Theme: Diagnosis and Prognosis
Session: PL-02-02
10:30 - 11 a.m.
The Winds of Change: Transformative Data Resources for Alzheimer’s Research
Richard Hodes, M.D.
National Institute on Aging, United States
Theme: Public Health and Psychosocial / Health Economics and Policy
Session: PL-03-01
11 - 11:30 a.m.
Psychosocial Research in Dementia: Past, Present and Future
Henry Brodaty, M.D.
UNSW Sydney, Australia
Theme: Public Health and Psychosocial
Session: PL-03-02
10:30 - 11 a.m.
Pathobiology of ApoE in Alzheimer’s Disease
Guojun Bu, Ph.D.
Mayo Clinic, United States
Theme: Diagnosis and Prognosis
Session: PL-04-01
11 - 11:30 a.m.
Communication Between the Immune System and the Brain
Michal Schwartz, Ph.D.
Weizmann Institute of Science, Israel
Theme: Basic and Translational Science
Session: PL-04-02
10:30 - 11:00 a.m.
Pathogenesis of Alzheimer's Disease: What Have We Learned From Neuroimaging?
Gil Rabinovici, M.D.
Memory and Aging Center, University of California, San Francisco, United States
Theme: Diagnosis and Prognosis
Session: PL-05-01
11:00 - 11:30 a.m.
AD Biomarker Epidemiology in the Aging Population: Prevalence, Risk Factors and Outcomes
Prashanthi Vemuri, Ph.D.
Mayo Clinic, United States
Theme: Public Health & Psychosocial
Session: PL-05-02
PRESENTATIONS
SPEAKERS
Approaches to Harmonize Neuropsychological Data Across Studies
Nicole Kochan
Centre for Healthy Brain Ageing, UNSW;
Neuropsychiatric Institute, Prince of Wales Hospital, Australia
Alternatives to Randomized Trials Using Simulations and Observational Data
Chung-Chou Chang
University of Pittsburgh
Graduate School of Public Health, United States
Analysis of Data from Wearable Devices
Aron Buchman
Rush Alzheimer's Disease Center;
Rush University Medical Center, United States
Epidemiology in the Era of Big Data
Robert Stewart
King’s College
London, United Kingdom
PRESENTATIONS
SPEAKERS
Review of GWAS Genes and Polygenic Risk Scores
Carlos Cruchaga
Washington University
School of Medicine, United States
Approaches Towards Understanding the Pathomechanism Underlying GWAS Gene Associations
Steven Estus
Sanders-Brown
Center on Aging, United States
Genetics of SORL1 and Its Role As APP Neuronal Sorting Receptor
Ekaterina Rogaeva
University of Toronto, Canada
Complex Mutations in ABCA7 Modify Disease Penetrance By Dosage Reduction
Kristel Sleegers
Institute Born-Bunge,
University of Antwerp;
Neurodegenerative Brain Diseases Group,
Center for Molecular Neurology, VIB, Belgium
PRESENTATIONS
SPEAKERS
Tau Pathology of Alzheimer's Disease
Charles Duyckaerts
Laboratoire de neuropathologie
Raymond Escourolle, France
Origins of Tau Accumulation
Lea Grinberg
University of California,
San Francisco, United States;
University of São Paulo Medical School, Brazil
Linking Post-Mortem MRI and Dense Histology
Paul Yushkevich
Penn Image Computing and Science Laboratory (PICSL),
University of Pennsylvania, United States
Tau Dissemination Patterns in the Brain Before and After Dementia
Val Lowe
Mayo Clinic, United States
PRESENTATIONS
SPEAKERS
New In Vivo Models for Alzheimer’s Disease – MODEL-AD
Bruce Lamb
Indiana University,
Stark Neurosciences Research Institute, United States
Translational Research – The View from Pharma
Samantha Budd Haeberlein
Biogen, United States
Progression of Synaptoprotective Sigma-2 Antagonists into the Clinic
Susan Catalano
Cognition Therapeutics Inc., United States
Targeting the p75 Neurotrophin Receptor – A New Approach for Alzheimer’s Disease
Frank Longo
Stanford University, United States
PRESENTATIONS
SPEAKERS
Effects of ApoE on Tau Mediated Neurodegeneration
David Holtzman
Washington University, United States
Apoe and Alzheimer’s Disease Imaging Biomarkers
Beth Mormino
Stanford University, United States
Apoe and Sex Differences on Alzheimer’s Disease Risk
Arthur Toga
University of Southern California, United States
Therapeutic Strategies: Apoe in Traumatic Brain Injury
Cheryl Wellington
University of British Columbia, Canada
PRESENTATIONS
SPEAKERS
Necroptosis Activation in Alzheimer’s Disease
Antonella Caccamo
Arizona State University, United States
Stress Granule Formation and Neuronal Death
Benjamin Wolozin
Boston University School of Medicine, United States
Neuroinflammatory Processes and Neurodegeneration
Roisin McManus
German Center for Neurodegenerative Diseases (DZNE), Germany
Microglial Activation in Neurodegenerative Diseases: Opportunities for Therapeutic Intervention
Diego Gomez-Nicola
University of Southampton, United Kingdom
PRESENTATIONS
SPEAKERS
The Relation Between Air Pollution Exposure and Dementia
Jennifer Weuve
Boston University School of Public Health, United States
Interaction between Pollutant Exposures and Genetics in Aging Populations at Risk for Cognitive Decline
Kelly Bakulski
University of Michigan, United States
Life Course Air Pollution Exposure and Cognitive Decline in Scotland: Modelled Historical Air Pollution Data and the Lothian Birth Cohort 1936
Tom Russ
University of Edinburgh,
United Kingdom
Traffic Noise Exposure and Mild Cognitive Impairment
Lilian Tzivian
University of Lativia, Lativia
PRESENTATIONS
SPEAKERS
Ageing and Neuroimmunology: The White Matter Pathology
Julie Simpson
University of Sheffield, United Kingdom
Astrocytes in Alzheimer’s Disease - Molecular Changes and Functional Consequences
Elly Hol
Brain Center Rudolf Magnus,
UMC Utrecht, Netherlands
Microglia: Dynamic Sensors of Neural Activity
Caroline Baufeld
Brigham and Women's Hospital,
United States
Oligodendrocytes in Dementia
Ragnhildur Thora Karadottir
University of Cambridge,
United Kingdom
Do you have research findings that were not yet available during the regular abstract submission period? Share them today for the chance to present your work during AAIC.
Join the Conversation #AAIC18